Connection

Syed Hasan to Pandemics

Back to Details
This is a "connection" page, showing publications Syed Hasan has written about Pandemics.
Syed Hasan
Connection Strength
0.528
Pandemics
  1. Dexamethasone or hydrocortisone in COVID-19? Cleve Clin J Med. 2020 11 23; 87(12):715.
    View in: PubMed
    Score: 0.031
  2. Use of rituximab and the risk of adverse clinical outcomes in COVID-19 patients with systemic rheumatic disease. Rheumatol Int. 2020 12; 40(12):2117-2118.
    View in: PubMed
    Score: 0.030
  3. The Use of Pharmacological Preventive Therapy for Migraine With Weight Gain Potential Amid Coronavirus Disease 2019 Pandemic. Headache. 2020 10; 60(9):2085-2086.
    View in: PubMed
    Score: 0.030
  4. Use of Azithromycin in COVID-19: A Cautionary Tale. Clin Drug Investig. 2020 10; 40(10):989-990.
    View in: PubMed
    Score: 0.030
  5. The use of antiplatelet agents for arterial thromboprophylaxis in COVID-19. Rev Esp Cardiol (Engl Ed). 2021 01; 74(1):114-115.
    View in: PubMed
    Score: 0.030
  6. Meta-analysis of Effect of Statins in Patients with COVID-19. Am J Cardiol. 2020 11 01; 134:153-155.
    View in: PubMed
    Score: 0.030
  7. Management of Outpatient Warfarin Therapy amid COVID-19 Pandemic: A Practical Guide. Am J Cardiovasc Drugs. 2020 Aug; 20(4):301-309.
    View in: PubMed
    Score: 0.030
  8. Role of frailty in COVID-19 patients. Intensive Care Med. 2020 10; 46(10):1956-1957.
    View in: PubMed
    Score: 0.030
  9. Possible Protective Effect of Renin-Angiotensin System Inhibitors in COVID-19 Induced Acute Kidney Injury. J Am Soc Nephrol. 2020 08; 31(8):1917-1918.
    View in: PubMed
    Score: 0.030
  10. Use of low-molecular-weight heparin in COVID-19 patients. J Vasc Surg Venous Lymphat Disord. 2020 09; 8(5):900-901.
    View in: PubMed
    Score: 0.030
  11. Cardiovascular Disease and Use of Renin-Angiotensin System Inhibitors in COVID-19. Am J Cardiovasc Drugs. 2020 Jun; 20(3):217-221.
    View in: PubMed
    Score: 0.030
  12. Use of corticosteroids in asthma and COPD patients with or without COVID-19. Respir Med. 2020 Aug - Sep; 170:106045.
    View in: PubMed
    Score: 0.030
  13. Glucocorticoid versus immunoglobulin in the treatment of COVID-19-associated fulminant myocarditis. Infection. 2020 10; 48(5):805-806.
    View in: PubMed
    Score: 0.029
  14. Innovating medication reviews through a technology-enabled process. Res Social Adm Pharm. 2022 04; 18(4):2700-2705.
    View in: PubMed
    Score: 0.008
  15. The risk of mortality in patients with COVID-19 with pre-diagnosis use of NSAIDs: a meta-analysis. Inflammopharmacology. 2021 Jun; 29(3):641-644.
    View in: PubMed
    Score: 0.008
  16. Effect of COVID-19 on viral hepatitis services in Pakistan. Lancet Gastroenterol Hepatol. 2021 03; 6(3):163-164.
    View in: PubMed
    Score: 0.008
  17. COVID-19 first anniversary review of cases, hospitalization, and mortality in the UK. Expert Rev Respir Med. 2021 08; 15(8):973-978.
    View in: PubMed
    Score: 0.008
  18. Pharmacological Management of Obese Patients with Type 2 Diabetes amid COVID-19 Pandemic. Obes Surg. 2021 01; 31(1):413-414.
    View in: PubMed
    Score: 0.008
  19. The use of combined hormonal contraceptives amid the COVID-19 pandemic. Eur J Contracept Reprod Health Care. 2021 02; 26(1):85-86.
    View in: PubMed
    Score: 0.008
  20. Use of Pharmacologic Agents With Weight Gain Potential for Panic Disorder Amid the COVID-19 Pandemic. Prim Care Companion CNS Disord. 2020 11 25; 22(6).
    View in: PubMed
    Score: 0.008
  21. Angiotensin-II receptor blockers or angiotensin converting enzyme inhibitors for the treatment of hypertension amid COVID-19 pandemic. Expert Rev Cardiovasc Ther. 2021 01; 19(1):99-100.
    View in: PubMed
    Score: 0.008
  22. Venous thromboembolism in critically ill COVID-19 patients receiving prophylactic or therapeutic anticoagulation: a systematic review and meta-analysis. J Thromb Thrombolysis. 2020 Nov; 50(4):814-821.
    View in: PubMed
    Score: 0.008
  23. Concurrent Antibiotic Therapy in Disseminated Strongyloidiasis. Am J Trop Med Hyg. 2020 11; 103(5):2149.
    View in: PubMed
    Score: 0.008
  24. Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis. Expert Rev Respir Med. 2020 11; 14(11):1149-1163.
    View in: PubMed
    Score: 0.008
  25. The Potential Benefit of Telmisartan to Protect Overweight Patients with COPD from the Acquisition of COVID-19. Obesity (Silver Spring). 2020 11; 28(11):2035.
    View in: PubMed
    Score: 0.008
  26. Montelukast in children with allergic rhinitis amid COVID-19 pandemic. Acta Paediatr. 2020 10; 109(10):2151.
    View in: PubMed
    Score: 0.007
  27. Revascularization strategy in patients with acute ST-elevation myocardial infarction amid COVID-19 pandemic. J Formos Med Assoc. 2021 01; 120(1 Pt 3):772-773.
    View in: PubMed
    Score: 0.007
  28. Anticoagulant approach in COVID-19 patients with cerebral venous thrombosis. J Stroke Cerebrovasc Dis. 2020 12; 29(12):105222.
    View in: PubMed
    Score: 0.007
  29. Pharmacotherapeutic considerations for the management of cardiovascular diseases among hospitalized COVID-19 patients. Expert Rev Cardiovasc Ther. 2020 Aug; 18(8):475-485.
    View in: PubMed
    Score: 0.007
  30. Metformin use amid coronavirus disease 2019 pandemic. J Med Virol. 2020 11; 92(11):2401-2402.
    View in: PubMed
    Score: 0.007
  31. Vitamin D Supplementation in Influenza and COVID-19 Infections Comment on: "Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths" Nutrients 2020, 12(4), 988. Nutrients. 2020 Jun 01; 12(6).
    View in: PubMed
    Score: 0.007
  32. Pharmacotherapy in COVID-19 patients: a review of ACE2-raising drugs and their clinical safety. J Drug Target. 2020 Aug-Sep; 28(7-8):683-699.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.